Pharmaceuticals
PharmaceuticalPharmaceuticals
Providers using this tag (629)
Ranked by API Evangelist rating — Exemplar and Strong are expanded by default.
Exemplar 1 Complete, well-documented, and agent-ready
Strong 1 Solid coverage with minor gaps
Developing 3 Usable, with meaningful gaps to close
Thin 7 Limited public surface area
Emerging 111 Early or largely undocumented
Minimal 496 Almost no public developer surface
APIs with this tag (2)
Ranked by the provider's API Evangelist rating — the Kin Score is scored per provider, not per API, so every API of a provider shares its band. How the rating works →
Minimal 2 Almost no public developer surface
Score breakdown
Where this tag sits
629 providers carry this tag directly, and 632 counting the 1 narrower tag below — 3 more to reach.
Related tags
Where this tag comes from
Markets provisional
Kin Score markets whose measured providers carry this tag. Share is the fraction of the market's measured providers that carry it — it describes the market, not this tag.
| Market | Share of the market's providers |
|---|---|
| EU Centrally Authorised Medicines (EMA marketing-authorisation holders) | 84% |
| Clinical Trial Sponsors (drug pipelines) | 71% |
| Cell & Gene Therapy | 44% |
Cohort brief
Auto-generatedThe 515 providers in the APIs.io catalog tagged Pharmaceuticals, scored on the Kin Score. Every figure below is computed from the catalog — nothing here is written.
| Facet | This cohort | Catalog | Difference | Scored |
|---|---|---|---|---|
| Discoverability | 51.7 | 57.9 | -6.2 | 515 |
| Contract Governance | 2.4 | 9.4 | -7 | 515 |
| Operational Transparency | 1.4 | 12.4 | -11 | 515 |
| Access Clarity | 12.4 | 25 | -12.6 | 515 |
| Developer Ergonomics | 6.5 | 22.1 | -15.6 | 515 |
| Contract Quality | 1.1 | 18.2 | -17.1 | 515 |
A facet is averaged over the members that carry it, not over the whole cohort — the “Scored” column is that count. Averaging an absent facet as zero would score our own coverage gaps as the providers’ posture.
| Artifact | This cohort | Catalog | Difference |
|---|---|---|---|
| MCP server (any) | 5% | 16% | -11 |
| MCP server (first-party) | 2% | 14% | -12 |
| Agent Skills | 0% | 0% | 0 |
| OAuth scopes | 2% | 13% | -11 |
| Security | 98% | 98% | 0 |
| Arazzo workflows | 0% | 2% | -2 |
| Governance rules | 3% | 35% | -32 |
mcp_pct counts any mcp/ artifact including ones API Evangelist derived from the provider OpenAPI; mcp_first_party_pct counts only servers the provider publishes. Prefer the latter.
- 1 Veeva 73.6
- 2 TraceLink 57.5
- 3 Tellius 50.9
- 4 Rhizome Ai 43.7
- 5 Biolevate 41.4
- 6 Biogen 39.2
- 7 myTomorrows 37.5
- 8 Doceree 36.6
- 9 Science Exchange 35
- 10 Collaborative Drug Discovery 34.3
- 1 Veeva 45.3
- 2 Tellius 44.2
- 3 Rhizome Ai 40.7
- 4 A2 Biotherapeutics 39.6
- 5 Biogen 32.9
- 6 Biolevate 32.5
- 7 Collaborative Drug Discovery 28.7
- 8 LifeMine 28.1
- 9 TraceLink 27.3
- 10 Roivant Sciences 26.9
Coverage caveat. 511 of 515 scored members had under half their catalog-attributable points satisfied at all (catalog_earned / catalog_max < 0.5). They are INCLUDED in the mean above. A large share here means the cohort mean is partly a measurement of how far our enrichment reached, not only of how these providers publish.Generated from the catalog build of 7 November 2026, across 38912 providers, using the same computation served by the APIs.io cohort API. Briefs are published for rosters of 5 or more scored providers; below that a distribution is not meaningful.
Work with this as data
Every tag here is available over the APIs.io API and to AI agents over MCP.